Vitamin D Receptor Agonist Market In Global
Vitamin D receptor (VDR) agonists emerge to retain pleiotropic anti-inflammatory properties, sinc ... Read More
1 Introduction to Research & Analysis Reports 1.1 Graves Disease Market Definition 1.2 Market Segments 1.2.1 Market by Type 1.2.2 Market by Application 1.3 Global Graves Disease Market Overview 1.4 Features & Benefits of This Report 1.5 Methodology & Sources of Information 1.5.1 Research Methodology 1.5.2 Research Process 1.5.3 Base Year 1.5.4 Report Assumptions & Caveats 2 Global Graves Disease Overall Market Size 2.1 Global Graves Disease Market Size: 2021 VS 2028 2.2 Global Graves Disease Market Size, Prospects & Forecasts: 2017-2028 2.3 Key Market Trends, Opportunity, Drivers and Restraints 2.3.1 Market Opportunities & Trends 2.3.2 Market Drivers 2.3.3 Market Restraints 3 Company Landscape 3.1 Top Graves Disease Players in Global Market 3.2 Top Global Graves Disease Companies Ranked by Revenue 3.3 Global Graves Disease Revenue by Companies 3.4 Top 3 and Top 5 Graves Disease Companies in Global Market, by Revenue in 2021 3.5 Global Companies Graves Disease Product Type 3.6 Tier 1, Tier 2 and Tier 3 Graves Disease Players in Global Market 3.6.1 List of Global Tier 1 Graves Disease Companies 3.6.2 List of Global Tier 2 and Tier 3 Graves Disease Companies 4 Market Sights by Product 4.1 Overview 4.1.1 by Type - Global Graves Disease Market Size Markets, 2021 & 2028 4.1.2 Anti-Thyroid Drugs 4.1.3 Lodine &Lodides 4.1.4 Radioactive Lodine 4.1.5 Lonic Inhibitors 4.2 By Type - Global Graves Disease Revenue & Forecasts 4.2.1 By Type - Global Graves Disease Revenue, 2017-2022 4.2.2 By Type - Global Graves Disease Revenue, 2023-2028 4.2.3 By Type - Global Graves Disease Revenue Market Share, 2017-2028 5 Sights by Application 5.1 Overview 5.1.1 By Application - Global Graves Disease Market Size, 2021 & 2028 5.1.2 Hospital Pharmacy 5.1.3 Online Pharmacy 5.1.4 Retail Pharmacy 5.2 By Application - Global Graves Disease Revenue & Forecasts 5.2.1 By Application - Global Graves Disease Revenue, 2017-2022 5.2.2 By Application - Global Graves Disease Revenue, 2023-2028 5.2.3 By Application - Global Graves Disease Revenue Market Share, 2017-2028 6 Sights by Region 6.1 By Region - Global Graves Disease Market Size, 2021 & 2028 6.2 By Region - Global Graves Disease Revenue & Forecasts 6.2.1 By Region - Global Graves Disease Revenue, 2017-2022 6.2.2 By Region - Global Graves Disease Revenue, 2023-2028 6.2.3 By Region - Global Graves Disease Revenue Market Share, 2017-2028 6.3 North America 6.3.1 By Country - North America Graves Disease Revenue, 2017-2028 6.3.2 US Graves Disease Market Size, 2017-2028 6.3.3 Canada Graves Disease Market Size, 2017-2028 6.3.4 Mexico Graves Disease Market Size, 2017-2028 6.4 Europe 6.4.1 By Country - Europe Graves Disease Revenue, 2017-2028 6.4.2 Germany Graves Disease Market Size, 2017-2028 6.4.3 France Graves Disease Market Size, 2017-2028 6.4.4 U.K. Graves Disease Market Size, 2017-2028 6.4.5 Italy Graves Disease Market Size, 2017-2028 6.4.6 Russia Graves Disease Market Size, 2017-2028 6.4.7 Nordic Countries Graves Disease Market Size, 2017-2028 6.4.8 Benelux Graves Disease Market Size, 2017-2028 6.5 Asia 6.5.1 By Region - Asia Graves Disease Revenue, 2017-2028 6.5.2 China Graves Disease Market Size, 2017-2028 6.5.3 Japan Graves Disease Market Size, 2017-2028 6.5.4 South Korea Graves Disease Market Size, 2017-2028 6.5.5 Southeast Asia Graves Disease Market Size, 2017-2028 6.5.6 India Graves Disease Market Size, 2017-2028 6.6 South America 6.6.1 By Country - South America Graves Disease Revenue, 2017-2028 6.6.2 Brazil Graves Disease Market Size, 2017-2028 6.6.3 Argentina Graves Disease Market Size, 2017-2028 6.7 Middle East & Africa 6.7.1 By Country - Middle East & Africa Graves Disease Revenue, 2017-2028 6.7.2 Turkey Graves Disease Market Size, 2017-2028 6.7.3 Israel Graves Disease Market Size, 2017-2028 6.7.4 Saudi Arabia Graves Disease Market Size, 2017-2028 6.7.5 UAE Graves Disease Market Size, 2017-2028 7 Players Profiles 7.1 Abbott Laboratories 7.1.1 Abbott Laboratories Corporate Summary 7.1.2 Abbott Laboratories Business Overview 7.1.3 Abbott Laboratories Graves Disease Major Product Offerings 7.1.4 Abbott Laboratories Graves Disease Revenue in Global Market (2017-2022) 7.1.5 Abbott Laboratories Key News 7.2 GlaxoSmithKline plc 7.2.1 GlaxoSmithKline plc Corporate Summary 7.2.2 GlaxoSmithKline plc Business Overview 7.2.3 GlaxoSmithKline plc Graves Disease Major Product Offerings 7.2.4 GlaxoSmithKline plc Graves Disease Revenue in Global Market (2017-2022) 7.2.5 GlaxoSmithKline plc Key News 7.3 Merck & Co 7.3.1 Merck & Co Corporate Summary 7.3.2 Merck & Co Business Overview 7.3.3 Merck & Co Graves Disease Major Product Offerings 7.3.4 Merck & Co Graves Disease Revenue in Global Market (2017-2022) 7.3.5 Merck & Co Key News 7.4 Pfizer, Inc 7.4.1 Pfizer, Inc Corporate Summary 7.4.2 Pfizer, Inc Business Overview 7.4.3 Pfizer, Inc Graves Disease Major Product Offerings 7.4.4 Pfizer, Inc Graves Disease Revenue in Global Market (2017-2022) 7.4.5 Pfizer, Inc Key News 7.5 RLC LABS 7.5.1 RLC LABS Corporate Summary 7.5.2 RLC LABS Business Overview 7.5.3 RLC LABS Graves Disease Major Product Offerings 7.5.4 RLC LABS Graves Disease Revenue in Global Market (2017-2022) 7.5.5 RLC LABS Key News 7.6 AbbVie, Inc 7.6.1 AbbVie, Inc Corporate Summary 7.6.2 AbbVie, Inc Business Overview 7.6.3 AbbVie, Inc Graves Disease Major Product Offerings 7.6.4 AbbVie, Inc Graves Disease Revenue in Global Market (2017-2022) 7.6.5 AbbVie, Inc Key News 7.7 Mylan N.V 7.7.1 Mylan N.V Corporate Summary 7.7.2 Mylan N.V Business Overview 7.7.3 Mylan N.V Graves Disease Major Product Offerings 7.7.4 Mylan N.V Graves Disease Revenue in Global Market (2017-2022) 7.7.5 Mylan N.V Key News 7.8 Allergan, plc 7.8.1 Allergan, plc Corporate Summary 7.8.2 Allergan, plc Business Overview 7.8.3 Allergan, plc Graves Disease Major Product Offerings 7.8.4 Allergan, plc Graves Disease Revenue in Global Market (2017-2022) 7.8.5 Allergan, plc Key News 8 Conclusion 9 Appendix 9.1 Note 9.2 Examples of Clients 9.3 Disclaimer
List of Tables Table 1. Graves Disease Market Opportunities & Trends in Global Market Table 2. Graves Disease Market Drivers in Global Market Table 3. Graves Disease Market Restraints in Global Market Table 4. Key Players of Graves Disease in Global Market Table 5. Top Graves Disease Players in Global Market, Ranking by Revenue (2021) Table 6. Global Graves Disease Revenue by Companies, (US$, Mn), 2017-2022 Table 7. Global Graves Disease Revenue Share by Companies, 2017-2022 Table 8. Global Companies Graves Disease Product Type Table 9. List of Global Tier 1 Graves Disease Companies, Revenue (US$, Mn) in 2021 and Market Share Table 10. List of Global Tier 2 and Tier 3 Graves Disease Companies, Revenue (US$, Mn) in 2021 and Market Share Table 11. By Type – Global Graves Disease Revenue, (US$, Mn), 2021 & 2028 Table 12. By Type - Graves Disease Revenue in Global (US$, Mn), 2017-2022 Table 13. By Type - Graves Disease Revenue in Global (US$, Mn), 2023-2028 Table 14. By Application – Global Graves Disease Revenue, (US$, Mn), 2021 & 2028 Table 15. By Application - Graves Disease Revenue in Global (US$, Mn), 2017-2022 Table 16. By Application - Graves Disease Revenue in Global (US$, Mn), 2023-2028 Table 17. By Region – Global Graves Disease Revenue, (US$, Mn), 2021 & 2028 Table 18. By Region - Global Graves Disease Revenue (US$, Mn), 2017-2022 Table 19. By Region - Global Graves Disease Revenue (US$, Mn), 2023-2028 Table 20. By Country - North America Graves Disease Revenue, (US$, Mn), 2017-2022 Table 21. By Country - North America Graves Disease Revenue, (US$, Mn), 2023-2028 Table 22. By Country - Europe Graves Disease Revenue, (US$, Mn), 2017-2022 Table 23. By Country - Europe Graves Disease Revenue, (US$, Mn), 2023-2028 Table 24. By Region - Asia Graves Disease Revenue, (US$, Mn), 2017-2022 Table 25. By Region - Asia Graves Disease Revenue, (US$, Mn), 2023-2028 Table 26. By Country - South America Graves Disease Revenue, (US$, Mn), 2017-2022 Table 27. By Country - South America Graves Disease Revenue, (US$, Mn), 2023-2028 Table 28. By Country - Middle East & Africa Graves Disease Revenue, (US$, Mn), 2017-2022 Table 29. By Country - Middle East & Africa Graves Disease Revenue, (US$, Mn), 2023-2028 Table 30. Abbott Laboratories Corporate Summary Table 31. Abbott Laboratories Graves Disease Product Offerings Table 32. Abbott Laboratories Graves Disease Revenue (US$, Mn), (2017-2022) Table 33. GlaxoSmithKline plc Corporate Summary Table 34. GlaxoSmithKline plc Graves Disease Product Offerings Table 35. GlaxoSmithKline plc Graves Disease Revenue (US$, Mn), (2017-2022) Table 36. Merck & Co Corporate Summary Table 37. Merck & Co Graves Disease Product Offerings Table 38. Merck & Co Graves Disease Revenue (US$, Mn), (2017-2022) Table 39. Pfizer, Inc Corporate Summary Table 40. Pfizer, Inc Graves Disease Product Offerings Table 41. Pfizer, Inc Graves Disease Revenue (US$, Mn), (2017-2022) Table 42. RLC LABS Corporate Summary Table 43. RLC LABS Graves Disease Product Offerings Table 44. RLC LABS Graves Disease Revenue (US$, Mn), (2017-2022) Table 45. AbbVie, Inc Corporate Summary Table 46. AbbVie, Inc Graves Disease Product Offerings Table 47. AbbVie, Inc Graves Disease Revenue (US$, Mn), (2017-2022) Table 48. Mylan N.V Corporate Summary Table 49. Mylan N.V Graves Disease Product Offerings Table 50. Mylan N.V Graves Disease Revenue (US$, Mn), (2017-2022) Table 51. Allergan, plc Corporate Summary Table 52. Allergan, plc Graves Disease Product Offerings Table 53. Allergan, plc Graves Disease Revenue (US$, Mn), (2017-2022) List of Figures Figure 1. Graves Disease Segment by Type in 2021 Figure 2. Graves Disease Segment by Application in 2021 Figure 3. Global Graves Disease Market Overview: 2021 Figure 4. Key Caveats Figure 5. Global Graves Disease Market Size: 2021 VS 2028 (US$, Mn) Figure 6. Global Graves Disease Revenue, 2017-2028 (US$, Mn) Figure 7. The Top 3 and 5 Players Market Share by Graves Disease Revenue in 2021 Figure 8. By Type - Global Graves Disease Revenue Market Share, 2017-2028 Figure 9. By Application - Global Graves Disease Revenue Market Share, 2017-2028 Figure 10. By Region - Global Graves Disease Revenue Market Share, 2017-2028 Figure 11. By Country - North America Graves Disease Revenue Market Share, 2017-2028 Figure 12. US Graves Disease Revenue, (US$, Mn), 2017-2028 Figure 13. Canada Graves Disease Revenue, (US$, Mn), 2017-2028 Figure 14. Mexico Graves Disease Revenue, (US$, Mn), 2017-2028 Figure 15. By Country - Europe Graves Disease Revenue Market Share, 2017-2028 Figure 16. Germany Graves Disease Revenue, (US$, Mn), 2017-2028 Figure 17. France Graves Disease Revenue, (US$, Mn), 2017-2028 Figure 18. U.K. Graves Disease Revenue, (US$, Mn), 2017-2028 Figure 19. Italy Graves Disease Revenue, (US$, Mn), 2017-2028 Figure 20. Russia Graves Disease Revenue, (US$, Mn), 2017-2028 Figure 21. Nordic Countries Graves Disease Revenue, (US$, Mn), 2017-2028 Figure 22. Benelux Graves Disease Revenue, (US$, Mn), 2017-2028 Figure 23. By Region - Asia Graves Disease Revenue Market Share, 2017-2028 Figure 24. China Graves Disease Revenue, (US$, Mn), 2017-2028 Figure 25. Japan Graves Disease Revenue, (US$, Mn), 2017-2028 Figure 26. South Korea Graves Disease Revenue, (US$, Mn), 2017-2028 Figure 27. Southeast Asia Graves Disease Revenue, (US$, Mn), 2017-2028 Figure 28. India Graves Disease Revenue, (US$, Mn), 2017-2028 Figure 29. By Country - South America Graves Disease Revenue Market Share, 2017-2028 Figure 30. Brazil Graves Disease Revenue, (US$, Mn), 2017-2028 Figure 31. Argentina Graves Disease Revenue, (US$, Mn), 2017-2028 Figure 32. By Country - Middle East & Africa Graves Disease Revenue Market Share, 2017-2028 Figure 33. Turkey Graves Disease Revenue, (US$, Mn), 2017-2028 Figure 34. Israel Graves Disease Revenue, (US$, Mn), 2017-2028 Figure 35. Saudi Arabia Graves Disease Revenue, (US$, Mn), 2017-2028 Figure 36. UAE Graves Disease Revenue, (US$, Mn), 2017-2028 Figure 37. Abbott Laboratories Graves Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022) Figure 38. GlaxoSmithKline plc Graves Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022) Figure 39. Merck & Co Graves Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022) Figure 40. Pfizer, Inc Graves Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022) Figure 41. RLC LABS Graves Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022) Figure 42. AbbVie, Inc Graves Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022) Figure 43. Mylan N.V Graves Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022) Figure 44. Allergan, plc Graves Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
67
Vitamin D receptor (VDR) agonists emerge to retain pleiotropic anti-inflammatory properties, sinc ... Read More
Biotinylated polyclonal antibodies offer a tremendous binding affinity of avidin for biotin which ... Read More
Loperamide, sold under the brand name Imodium, among others, is a medication used to decrease the ... Read More
Zirconium Oxide Flap Disc is a 3-dimensional abrasive product. They consist of abrasive flaps whi ... Read More